Hidden Fees & Spread Pricing
Administrative fees, pricing spreads, claim markups, and undisclosed economics can materially increase pharmacy benefit costs.
Where Oversight Meets Accountability.
Pharmacy Benefit Manager Forensic Audit
A forensic PBM audit helps employers, plan sponsors, funds, trusts, healthcare organizations, and independent pharmacies uncover hidden costs, validate contract performance, recover missed value, and strengthen oversight of pharmacy benefit programs.
The PBM Problem
PBM contracts are often intentionally complex, and plan sponsors rarely receive enough actionable information to confirm that discounts, rebates, dispensing fees, guarantees, and utilization patterns align with the contract.
Administrative fees, pricing spreads, claim markups, and undisclosed economics can materially increase pharmacy benefit costs.
Manufacturer rebate arrangements are often difficult to verify without reviewing contract terms, reconciliation data, and payment reports.
PBMs may fail to meet contractual guarantees for discounts, dispensing fees, rebates, specialty claims, or other financial terms.
Without monthly reporting and independent review, employers and pharmacies often lack leverage to challenge PBM performance.
Executive-Level Visibility
The PBM Forensic Audit converts dense contract terms, rebate files, claims data, and utilization trends into a clear executive view of financial leakage, contractual variance, and recovery opportunity.
PBM Forensic Audit Solution
The audit identifies overpayments, missed rebates, contract inefficiencies, guarantee failures, and pharmacy spend drivers that are often invisible without a focused forensic review.
What We Review
What We Identify
Interactive Audit View
Review claims transaction data, AWP values, MAC pricing, dispensing fees, specialty claims, administrative fees, and member cost share to identify overpayments and pricing issues.
Evaluate rebate guarantee terms, manufacturer rebate reports, reconciliation files, and whether the PBM passed through the value required under the agreement.
Compare PBM performance against contract definitions, amendments, pricing exhibits, guarantee schedules, carve-outs, and audit rights.
Continue tracking PBM performance against guarantees, utilization trends, top drugs, pharmacy channels, specialty spend, and emerging recovery opportunities.
Audit Process
The process is designed so your team provides the PBM contract and directs the PBM to release claims data. From there, the audit team performs the review, quantifies findings, and supports recovery and ongoing monitoring.
Provide the current PBM contract, amendments, pricing exhibits, rebate terms, and guarantee schedules.
Direct the PBM and related vendors to provide claims, rebate, guarantee, invoice, and reconciliation files.
Review detailed findings identifying recoveries, performance shortfalls, pricing issues, and savings opportunities.
Use the findings to pursue recovery from the PBM and continue monthly monitoring to protect future performance.
Two Audit Paths
The PBM engagement can be structured as a historical forensic audit, ongoing monthly monitoring, or a combined engagement. Clients can choose one path, the other, or both based on current priorities, PBM contract restrictions, timing, and budget preferences.
Audit One
We review the prior 12 to 24 months of PBM contracts, claims, rebate reports, pricing guarantees, dispensing fees, invoices, specialty claims, and performance calculations to identify recoveries, overpayments, pricing discrepancies, and contract failures.
Audit Two
This audit can be selected independently or paired with a historical review. Monthly monitoring helps your organization avoid dependence on PBM self-reporting and identify missed performance, emerging cost trends, and contract variances before they become larger losses.
Measurable Financial Impact
Organizations can uncover 10%–20% or more in pharmacy spend opportunity through retrospective analysis, pricing validation, rebate reconciliation, and improved contract oversight.
Fiduciary Oversight
Employers sponsoring self-insured health plans must act prudently and solely in the interest of plan participants. PBM oversight is increasingly central to that responsibility.
Recent lawsuits against large employers highlight allegations of inadequate PBM oversight, inflated prescription costs, and failure to monitor plan vendors.
Employers must ensure plan costs are reasonable, third-party vendors are monitored, and plan assets are managed in participants’ best interests.
A forensic PBM audit creates documentation, financial findings, and oversight processes that help demonstrate prudent vendor monitoring.
How The Audit Helps
The audit translates complex PBM contract language, claims data, pricing files, and rebate information into clear financial findings and a practical roadmap for recovery and improved governance.
Identify inflated pricing, hidden spread margins, claim overpayments, and undisclosed financial leakage.
Evaluate whether the PBM contract and execution align with pricing guarantees, rebate terms, and fiduciary standards.
Compare pharmacy performance against contract expectations, market norms, and utilization trends.
Use audit findings to pursue recoveries, improve contract terms, and strengthen future PBM oversight.
Monthly Report Monitoring
After the initial review, ongoing reporting helps ensure no dollars are left on the table and that PBM performance remains aligned with contractual obligations.
Audit PBM performance against contract guarantees for discounts, dispensing fees, rebate pass-throughs, and financial terms.
Identify top costly and frequently used brand, generic, specialty, and high-cost drugs driving pharmacy spend.
Gain insight into top pharmacies, top patients, member cost trends, and claim utilization patterns requiring oversight.
Flexible Fee Structure
Some PBM contracts permit contingency-based audits, while others restrict or prohibit them. CGM structures the engagement around the client’s PBM contract terms so the audit can move forward without unnecessary friction.
If contingency-based audit fees are not permitted, we first perform an initial analysis to estimate potential revenue recovery, pricing variance, rebate leakage, and overall savings opportunity before the full audit begins.
When permitted, recoveries may be structured through a client-focused contingency model where the client retains the majority of identified recovery value and CGM is compensated based on measurable results.
When contingency fees are not allowed, CGM can perform the PBM forensic audit under a fixed-fee structure based on the scope, available data, number of plans, and complexity of the PBM arrangement.
Traditional PBM Oversight vs. CGM PBM Forensic Audit
Support for Independent Pharmacies
PBM pressure is not limited to employer-sponsored plans. Independent pharmacies can also use PBM audit and monitoring support to identify reimbursement issues, contract discrepancies, PSAO concerns, margin erosion, clawback exposure, and claims that may create compliance risk.
Compare reimbursement amounts to acquisition cost, NADAC or other pricing benchmarks, and identify drugs where reimbursement falls below cost.
Review PBM and PSAO performance, identify discrepancies, and determine whether contract economics are quietly reducing pharmacy margin.
Gain better visibility into high-risk claims, PBM red flags, audit exposure, and reimbursement behavior that may trigger chargebacks or penalties.
Use defensible reporting and claims analysis to challenge unfair reimbursement, support renegotiation, and strengthen PBM-related decision-making.
Begin With Clarity
Start with a PBM Forensic Audit and gain the transparency, documentation, and financial recovery insight needed to hold your PBM accountable.
The forensic audit methodology utilized in our PBM Audit was developed under the leadership of Dr. Susan A. Hayes, one of the most recognized experts in the United States in pharmacy benefit management auditing, healthcare fraud investigation, and pharmacy claims analytics. Dr. Hayes has more than 40 years of experience in the healthcare consulting and pharmacy benefit management industry and has held leadership roles with Walgreens Healthcare Plus, Systemed Pharmacy, William M. Mercer, Towers Perrin, and Hewitt Associates specializing in pharmacy benefit auditing and PBM procurement. Dr. Hayes currently serves as Director of the Health Informatics Master’s Degree Program at Roosevelt University and is the founder of Pharmacy Investigators and Consultants, a firm specializing in pharmacy benefit consulting, healthcare fraud investigations, and forensic analytics. She has served as an expert witness in numerous PBM litigation matters, including the landmark Rutledge v. PCMA case before the United States Supreme Court concerning state authority to regulate PBM practices.

112 Giffordtown Lane
Suite E
Little Egg Harbor, NJ 08087
(407) 796-2635
CG Moneta | All Rights Reserved | Privacy Policy |